Lupin gains on launching generic Lodosyn tablets in US

26 Mar 2018 Evaluate

Lupin is currently trading at Rs. 738.60, up by 2.85 points or 0.39% from its previous closing of Rs. 735.75 on the BSE.

The scrip opened at Rs. 737.00 and has touched a high and low of Rs. 741.95 and Rs. 727.05 respectively. So far 75329 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1496.85 on 24-Mar-2017 and a 52 week low of Rs. 727.05 on 26-Mar-2018.

Last one week high and low of the scrip stood at Rs. 779.70 and Rs. 727.50 respectively. The current market cap of the company is Rs. 33445.09 crore.

The promoters holding in the company stood at 47.02%, while Institutions and Non-Institutions held 37.64% and 15.35% respectively.

Lupin has launched its Carbidopa Tablets 25mg having received an approval from the United States Food and Drug Administration (USFDA) earlier.

Lupin’s Carbidopa Tablets, 25mg is the generic equivalent of Aton Pharma, Inc.’s Lodosyn Tablets, 25 mg. It is indicated for use with carbidopa-levodopa or with levodopa in the treatment of the symptoms of idiopathic Parkinson’s disease (paralysis agitans), postencephalitic parkinsonism, and symptomatic parkinsonism, which may follow injury to the nervous system by carbon monoxide intoxication and/or manganese intoxication.

Carbidopa Tablets, 25mg had annual sales of around $17.4 million in the US (IQVIA MAT January 2018).

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.

Lupin Share Price

2137.15 -27.90 (-1.29%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×